Stanford researchers discovered how plant cells decide whether to form breathing pores based on size and neighbor signals.

Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...

The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ( ...

The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...

Zegfrovy is designed to target a broad range of EGFR mutations while maintaining selectivity over wild-type EGFR.

Scientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

A gel-based cleanser is ideal for summer. It lifts away sweat, sunscreen, and grime without leaving the skintight or dry. Ingredients like white tea extract, known for its antioxidant benefits and ...

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

New data from the Environmental Working Group reveals only a fraction of sunscreens meet safety standards, with some posing health risks.

When celebrated actor, Natthawut "Poh" Skidjai, revealed on his YouTube channel @PohSakidAey that his wife Aey Pornthip had been diagnosed with stage one lung cancer after an annual health checkup, ...